Emma D'Agostino - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Emma D'Agostino's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Emma D'Agostino
Verified
Reporter, ABC News (Australia)
Bendigo
Beats
Health General Practice
clinical trial initiation, new product launches
Content
By Suzanne G. Mays, Emma D'Agostino Verified, Autumn R. Flynn, Xiangsheng Huang| Texas Medical Center@ KeywordsAnimals, Colitis, Ligands, Mice, Phospholipids, Receptors, Cytoplasmic and Nuclear, Phospholipid, LRH-1, nuclear receptor, agonist, ulcerative colitisAbstractPhospholipids are ligands for nuclear hormone receptors (NRs) that regulate transcriptional programs relevant to normal physiology and disease. Here, we demonstrate that mimicking phospholipid-NR interactions is a robust strategy to improve agonists of liver receptor homolog-1 (LRH-1), a therapeutic target for colitis.
By Emma D'Agostino Verified| ABC News (Australia) Verified The Australian pig industry hopes work to develop a vaccine to protect its animals against Japanese encephalitis virus can be expedited. There is no animal vaccine registered for use in Australia to protect pigs from the mosquito-borne disease. Researchers and Australian Pork Limited say there is an urgent need for a JEV vaccine for pigs, and are appealing to the regulator for support.
By Suzanne G. Mays, Emma D'Agostino Verified, Autumn R. Flynn, Xiangsheng Huang| Texas Medical Center@ KeywordsAnimals, Colitis, Ligands, Mice, Phospholipids, Receptors, Cytoplasmic and Nuclear, Phospholipid, LRH-1, nuclear receptor, agonist, ulcerative colitisAbstractPhospholipids are ligands for nuclear hormone receptors (NRs) that regulate transcriptional programs relevant to normal physiology and disease. Here, we demonstrate that mimicking phospholipid-NR interactions is a robust strategy to improve agonists of liver receptor homolog-1 (LRH-1), a therapeutic target for colitis.
Company Info
ABC News (Australia)
Annandale, Virginia, United States
+61 2 8333 1500